Bigelow Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$746K Sell
6,203
-511
-8% -$59K 0.3% 86
2025
Q4
$707K Sell
6,714
-408
-6% -$38.3K 0.28% 90
2025
Q3
$598K Sell
7,122
-518
-7% -$42.7K 0.24% 95
2025
Q2
$605K Sell
7,640
-1,170
-13% -$93K 0.27% 95
2025
Q1
$791K Sell
8,810
-3,670
-29% -$343K 0.38% 79
2024
Q4
$1.24M Sell
12,480
-1,046
-8% -$108K 0.58% 48
2024
Q3
$1.54M Sell
13,526
-528
-4% -$62.7K 0.68% 40
2024
Q2
$1.74M Sell
14,054
-335
-2% -$43.2K 0.83% 30
2024
Q1
$1.9M Sell
14,389
-1,012
-7% -$125K 0.93% 30
2023
Q4
$1.68M Sell
15,401
-300
-2% -$31.1K 0.91% 29
2023
Q3
$1.62M Sell
15,701
-53
-0.3% -$5.71K 0.93% 28
2023
Q2
$1.82M Buy
15,754
+95
+0.6% +$10.8K 0.99% 24
2023
Q1
$1.67M Sell
15,659
-527
-3% -$56.9K 0.96% 26
2022
Q4
$1.8M Sell
16,186
-410
-2% -$41.9K 1.04% 23
2022
Q3
$1.43M Buy
16,596
+465
+3% +$41.5K 0.85% 32
2022
Q2
$1.47M Buy
16,131
+666
+4% +$59K 0.81% 36
2022
Q1
$1.27M Buy
15,465
+231
+2% +$18.2K 0.59% 48
2021
Q4
$1.17M Buy
15,234
+32
+0.2% +$2.55K 0.53% 51
2021
Q3
$1.14M Sell
15,202
-776
-5% -$59K 0.56% 49
2021
Q2
$1.24M Sell
15,978
-805
-5% -$59.9K 0.6% 43
2021
Q1
$1.24M Sell
16,783
-71
-0.4% -$5.24K 0.63% 43
2020
Q4
$1.32M Sell
16,854
-52
-0.3% -$3.98K 0.7% 38
2020
Q3
$1.34M Sell
16,906
-131
-0.8% -$10.3K 0.79% 34
2020
Q2
$1.26M Buy
17,037
+307
+2% +$23.1K 0.82% 33
2020
Q1
$1.23M Sell
16,730
-207
-1% -$16.3K 0.92% 25
2019
Q4
$1.47M Sell
16,937
-84
-0.5% -$6.9K 0.86% 30
2019
Q3
$1.37M Sell
17,021
-121
-0.7% -$9.7K 0.87% 31
2019
Q2
$1.37M Sell
17,142
-743
-4% -$56.9K 0.92% 26
2019
Q1
$1.42M Sell
17,885
-20,193
-53% -$1.51M 0.98% 24
2018
Q4
$2.78M Buy
+38,078
New +$2.69M 2.07% 9

Other funds holding MRK

Bigelow Investment Advisors's MRK Position: Q1 2026 in Review

Bigelow Investment Advisors reduced its Merck (MRK) stake by 7.6% in Q1 2026, selling an estimated $59K and leaving 6,203 shares worth $746K. The position accounts for 0.3% of the portfolio, ranked #86.

Bigelow Investment Advisors first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.78M in Q4 2018. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bigelow Investment Advisors held 6,203 shares of Merck worth $746K as of Q1 2026.
  • Bigelow Investment Advisors sold 511 Merck shares in Q1 2026, an estimated $59K.
  • Merck made up 0.3% of Bigelow Investment Advisors's portfolio in Q1 2026, its #86 holding.
  • Bigelow Investment Advisors first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Bigelow Investment Advisors's Merck position peaked at $2.78M in Q4 2018.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bigelow Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.